or
forgot password

    • cancer clinical trials in vienna, VA

    • An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    MS Center of Greater Washington
    Vienna, Virginia
    Multiple Sclerosis, Relapsing-Remitting
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    MS Center of Greater Washington
    Vienna, Virginia
    Multiple Sclerosis, Relapsing-Remitting